New 2H-tetrahydro-1,3,5-thiadiazine-2-thiones incorporating glycine and glycinamide as potential antifungal agents

Archiv der Pharmazie

Volumn 335, Issue 9, 2002, Pages 438-442

  Aboul Fadl, Tarek ^a   Hussein, Mostafa A ^a   El Shorbagi, Abdel Nasser ^a   Khallil, Abdel Raouf ^b  

^a Assiut University   (Egypt)

^b Assiut University   (Egypt)

Author keywords

3,5 Disubstituted 2H tetrahydro 1,3,5 thiadiazine 2 thiones; Antifungal activity; Glycinamide; Glycine

Indexed keywords

2H TETRAHYDRO 1,3,5 THIADIAZINE 2 THIONE DERIVATIVE; AMINE; ANTIFUNGAL AGENT; CARBON DISULFIDE; FORMALDEHYDE; GLYCINAMIDE; GLYCINE; THIADIAZINE DERIVATIVE; UNCLASSIFIED DRUG;

ANTIFUNGAL ACTIVITY; ARTICLE; ASPERGILLUS FLAVUS; CANDIDA ALBICANS; CHEMICAL REACTION; CONTROLLED STUDY; DRUG SYNTHESIS; FASARIUM OXYSPORUM; FUNGUS; GROWTH INHIBITION; IN VITRO STUDY; NONHUMAN; PENICILLIUM EXPANSUM; POLARIZATION; PRIORITY JOURNAL; SPOROGENESIS; TRICHODERMA HARZIANUM; TRICHOPHYTON RUBRUM;

ANTIFUNGAL AGENTS; FUNGI; GLYCINE; MAGNETIC RESONANCE SPECTROSCOPY; SPORES, FUNGAL; THIADIAZINES;

EID: 0036861885     PISSN: 03656233     EISSN: None     Source Type: Journal    
DOI: 10.1002/1521-4184(200212)335:9<438::AID-ARDP438>3.0.CO;2-E     Document Type: Article

References (19)

1. M. E. Wolf, Burger's Medicinal Chemistry, 4th Ed. John Wiley and Sons, New York 1979, p. 531.
2. M. Schorr, W. Durrcheimer, R Klatt, G. Lommler, G. Nesemann, E. Schrinner, Arzneim-Forsch./Drug Res. 1969, 19, 1807-1819.
3. M. Ertan, A. B. Tayhan, N. Yulug, Arch. Pharm. 1990, 323, 605-609.
4. M. Ertan, S. Sarac, N. Yulug, Arzneim-Forsch./Drug Res. 1990, 40, 790-795.
5. S. Sarac, M. Ertan, A. Balkan, Arch. Pharm. 1991, 324, 449-453.
6. M. Ertan, A. A. Bilgin, E. Palaska, N. Yulug, ArzneimForsch./Drug Res. 1992, 42, 160-163.
7. I. Eser, C. Gueltaze, E. Nedime, U. Melten, K. Muammer, K. Dilek, Farmaco 1995, 50, 787-790.
8. M. Ertan, H. G. Ayyildiz, N. Yulug, Arzneim-Forsch./Drug Res. 1991, 41, 1182-1185.
9. C. Ochoa, E. Perez, R. Perez, M. Suarez, E. Ocho, H. Rodriguez, A. G. Barrio, S. Muelas, J. J. Nogal, R. A. Martinez, Arzneim-Forsch./Drug Res. 1999, 49, 764-769.
10. A. El-Shorbagi, Arch. Pharm. Pharm. Med. Chem., 2000, 333, 281-286.
11. T. Aboul-Fadl, M. A. Hussein, and A. El-Shrobagi, presented in the 27th Int. Conf. of Pharm. Sciences, Jan. 2000, Cairo, Egypt.
12. A. El-Shorbagi, Eur. J. Med. Chem. 1994, 29, 11-16.
13. M. A. Hussein, A. El-Shrobagi, A. Khallil, Arch. Pharm. Med. Chem. 2001, 334, 305-308.
14. T. Aboul-Fadl, A. El-Shorbagi, Eur. J. Med. Chem. 1996, 31, 165-169.
15. T. Aboul-Fadl, A. El-Shorbagi, Arch. Pharm. Pharm. Med. Chem. 1997, 330, 327-332.
16. T. Aboul-Fadl, K. Hassanin, Pharmazie 1999, 54, 244-247.
17. S. T. Pai, M. W. Platt, Lett. Appl. Microbiol. 1995, 20, 14.
18. K. J. Kwon-Chung, J. E. Bennett, Medical Mycology. Lea and Febiger, Malvern, Pennsylvania, USA, 1992, p. 866.
19. A. A. H. Moubasher, M. B. Mazen, A. M. Moharram, A. El-Shanawany, Assiut Govemorate. Proc. 10th Ann. Sci. Conf. April 1992.